CIITA B-cell-specific promoter suppression in MHC class II-silenced cell hybrids

被引:7
作者
Lennon, AM
Ottone, C
Rosemblatt, M
Fellous, M
Bono, MR
Alcaïde-Loridan, C
机构
[1] Inst Pasteur, INSERM, Unite Immunogenet Humaine, F-75724 Paris 15, France
[2] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile
关键词
silencing; MHC class II; CIITA; somatic cell hybrid;
D O I
10.1007/s002510050433
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
In this study, various sets of somatic cell hybrids, generated by the fusion of epithelial cell lines with B-lymphoblastoid cell lines, were analyzed for the expression of major histocompatibility complex (MHC) class II antigens. We first demonstrate, in human and mouse intraspecies hybrids, the coordinate suppression of MHC class II, Ii (invariant chain) and HLA-DM gene transcription, and the release of the silencing by the addition of interferon gamma. Using interspecies hybrids, the segregation of human chromosomes allowed us to establish that MHC class II extinction is linked to the presence in the hybrids of the chromosomes from the epithelial fusion partner. Moreover, our data provide evidence that the expression pattern of MHC class II mRNA is correlated with that of the class II transactivator (CIITA), suggesting that CIITA is the actual target of the silencing. To gain further insight into the suppression phenomenon we performed luciferase assays which show that silencing affects the activity of the B-cell-specific promoter of CIITA. These results therefore demonstrate that the MHC class II gene silencing in somatic cell hybrids is due to an active suppression of one of the promoters of the CIITA gene, mediated by the epithelial cell fusion partner.
引用
收藏
页码:283 / 291
页数:9
相关论文
共 39 条
[11]   IMMUNE INTERFERON ACTIVATES MULTIPLE CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX GENES AND THE ASSOCIATED INVARIANT CHAIN GENE IN HUMAN-ENDOTHELIAL CELLS AND DERMAL FIBROBLASTS [J].
COLLINS, T ;
KORMAN, AJ ;
WAKE, CT ;
BOSS, JM ;
KAPPES, DJ ;
FIERS, W ;
AULT, KA ;
GIMBRONE, MA ;
STROMINGER, JL ;
POBER, JS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (15) :4917-4921
[12]  
DELLABONA P, 1989, J IMMUNOL, V142, P2902
[13]   RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency [J].
Durand, B ;
Sperisen, P ;
Emery, P ;
Barras, E ;
Zufferey, M ;
Mach, B ;
Reith, W .
EMBO JOURNAL, 1997, 16 (05) :1045-1055
[14]   The class II trans-activator CIITA interacts with the TBP-associated factor TAF(II)32 [J].
Fontes, JD ;
Jiang, B ;
Peterlin, BM .
NUCLEIC ACIDS RESEARCH, 1997, 25 (12) :2522-2528
[15]   MHC-DEPENDENT ANTIGEN-PROCESSING AND PEPTIDE PRESENTATION - PROVIDING LIGANDS FOR T-LYMPHOCYTE ACTIVATION [J].
GERMAIN, RN .
CELL, 1994, 76 (02) :287-299
[16]   SEQUENCES AND FACTORS - A GUIDE TO MHC CLASS-II TRANSCRIPTION [J].
GLIMCHER, LH ;
KARA, CJ .
ANNUAL REVIEW OF IMMUNOLOGY, 1992, 10 :13-49
[17]  
GOURDEAU H, 1990, ANNU REV CELL BIOL, V6, P69, DOI 10.1146/annurev.cellbio.6.1.69
[18]  
HALPER J, 1978, J IMMUNOL, V120, P1480
[19]   ANTIGEN-INDUCIBLE, H-2-RESTRICTED, INTERLEUKIN-2-PRODUCING T-CELL HYBRIDOMAS - LACK OF INDEPENDENT ANTIGEN AND H-2 RECOGNITION [J].
KAPPLER, JW ;
SKIDMORE, B ;
WHITE, J ;
MARRACK, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 153 (05) :1198-1214
[20]   A NEW HUMAN HLA CLASS-II-RELATED LOCUS, DM [J].
KELLY, AP ;
MONACO, JJ ;
CHO, SG ;
TROWSDALE, J .
NATURE, 1991, 353 (6344) :571-573